PRLD
Prelude
--
--(--)
Market Open: --
--
--(--)
Post-Market: --
PRLD Profile
Prelude Therapeutics Incorporated
A clinical-stage precision oncology company that developing innovative drug candidates for cancer
Biological Technology
02/05/2016
09/25/2020
NASDAQ Stock Exchange
131
12-31
Common stock
175 Innovation Boulevard, Wilmington, Delaware 19805
--
Prelude Therapeutics Incorporated, founded in Delaware on February 5, 2016, is a clinical-stage precision oncology company dedicated to discovering and developing small molecule therapies optimized for key driving mechanisms of highly unmet cancer needs.